Kennedy Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,822
| Closed | -$768K | – | 690 |
|
|
2025
Q1 | $768K | Buy |
5,822
+75
| +1% | +$9.89K | 0.02% | 549 |
|
|
2024
Q4 | $480K | Buy |
5,747
+1,065
| +23% | +$88.9K | 0.01% | 636 |
|
|
2024
Q3 | $343K | Buy |
4,682
+1,108
| +31% | +$81.1K | 0.01% | 649 |
|
|
2024
Q2 | $245K | Sell |
3,574
-15,747
| -82% | -$1.08M | 0.01% | 674 |
|
|
2024
Q1 | $1.34M | Sell |
19,321
-8,046
| -29% | -$557K | 0.03% | 591 |
|
|
2023
Q4 | $1.96M | Sell |
27,367
-2,450
| -8% | -$175K | 0.04% | 496 |
|
|
2023
Q3 | $1.55M | Sell |
29,817
-39,917
| -57% | -$2.08M | 0.04% | 505 |
|
|
2023
Q2 | $4.42M | Sell |
69,734
-38,620
| -36% | -$2.45M | 0.1% | 318 |
|
|
2023
Q1 | $5.87M | Sell |
108,354
-200,292
| -65% | -$10.8M | 0.17% | 222 |
|
|
2022
Q4 | $16.3M | Sell |
308,646
-14,963
| -5% | -$792K | 0.46% | 37 |
|
|
2022
Q3 | $15.1M | Buy |
323,609
+70,290
| +28% | +$3.27M | 0.44% | 45 |
|
|
2022
Q2 | $14.5M | Buy |
253,319
+12,064
| +5% | +$689K | 0.41% | 55 |
|
|
2022
Q1 | $14.8M | Buy |
241,255
+36,433
| +18% | +$2.23M | 0.35% | 74 |
|
|
2021
Q4 | $10.7M | Buy |
204,822
+106,466
| +108% | +$5.57M | 0.23% | 155 |
|
|
2021
Q3 | $3.67M | Buy |
+98,356
| New | +$3.67M | 0.08% | 400 |
|